Over 30% Covaxin takers reported adverse events, claims BHU study
New Delhi: Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow-up study conducted by a team of researchers at BHU. Nearly 50 per cent of 926 study participants in...